LAB FY 2015 Earnings — Standard BioTools Inc. Revenue & Financial Results | Market Cap Arena

LABStandard BioTools Inc.

$370M

FY 2015 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$115M-1.5% YoY

Gross Profit

$68M59.4% margin

Operating Income

-$50M-43.7% margin

Net Income

-$53M-46.5% margin

EPS (Diluted)

$-1.86

Cash Flow

Operating Cash Flow

-$35M

Free Cash Flow

-$45M

Stock-Based Comp.

$17M

Balance Sheet

Total Assets

$371M

Total Liabilities

$256M

Stockholders' Equity

$115M

Cash & Equivalents

$29M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$115M	$116M	-1.5%
Gross Profit	$68M	$74M	-7.5%
Operating Income	-$50M	-$52M	+3.2%
Net Income	-$53M	-$53M	-0.9%